News

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...
Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more ...
Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly ...
A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...
Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...
The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...
It’s unclear what — if any — impact the Republican president’s executive order will have on millions of Americans who have ...
UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...
When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...